Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer's disease to AIDS

Journal of Lipid Research

Volumn 50, Issue SUPPL., 2009, Pages

  Mahley, Robert W ^a,b,c,d   Weisgraber, Karl H ^a,b,d   Huang, Yadong ^a,b,d  

^a GLADSTONE INSTITUTE OF NEUROLOGICAL DISEASE   (United States)

^b GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cholesterol; Coronary heart disease; Dysbetalipoproteinemia; Evolution; Heparan sulfate proteoglycans; HIV; Infectious diseases; LDL receptor; Neurodegeneration

Indexed keywords

APOLIPOPROTEIN E;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; ANIMAL; ARTICLE; ATHEROSCLEROSIS; CHEMISTRY; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PROTEIN BINDING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; HUMANS; PROTEIN BINDING;

EID: 66349085616     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R800069-JLR200     Document Type: Review

References (57)

1. Mahley, R. W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240: 622-630.
2. Weisgraber, K. H. 1994. Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45: 249-302. (Pubitemid 24139890)
3. Mahley, R. W., and S. C. Rall, Jr. 2000. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 1: 507-537.
4. Mahley, R. W., K. H. Weisgraber, and Y. Huang. 2006. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 103: 5644-5651.
5. Shore, V. G., and B. Shore. 1973. Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components. Biochemistry. 12: 502-507.
6. Mahley, R. W. 1983. Development of accelerated atherosclerosis. Concepts derived from cell biology and animal model studies. Arch. Pathol. Lab. Med. 107: 393-399. (Pubitemid 13076838)
7. Zannis, V. I., J. L. Breslow, G. Utermann, R. W. Mahley, K. H. Weisgraber, R. J. Havel, J. L. Goldstein, M. S. Brown, G. Schonfeld, W. R. Hazzard, et al. 1982. Proposed nomenclature of apoE iso-proteins, apoE genotypes, and phenotypes. J. Lipid Res. 23: 911-914. (Pubitemid 13244364)
8. Utermann, G., M. Hees, and A. Steinmetz. 1977. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature. 269: 604-607.
9. Zannis, V. I., P. W. Just, and J. L. Breslow. 1981. Human apolipoprotein E isoprotein subclasses are genetically determined. Am. J. Hum. Genet. 33: 11-24. (Pubitemid 11188459)
10. Havel, R. J., and J. P. Kane. 1973. Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins. Proc. Natl. Acad. Sci. USA. 70: 2015-2019.
11. Weisgraber, K. H., S. C. Rall, Jr., and R. W. Mahley. 1981. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J. Biol. Chem. 256: 9077-9083. (Pubitemid 12208303)
12. Rall, S. C., Jr., K. H. Weisgraber, and R. W. Mahley. 1982. Human apolipoprotein E. The complete amino acid sequence. J. Biol. Chem. 257: 4171-4178.
13. Taylor, J. M., W. S. Simonet, S. J. Lauer, G. Zhu, and D. Walker. 1993. Regulation and expression of the human apolipoprotein E gene in transgenic mice. Curr. Opin. Lipidol. 4: 84-89. (Pubitemid 23108632)
14. Grehan, S., E. Tse, and J. M. Taylor. 2001. Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain. J. Neurosci. 21: 812-822. (Pubitemid 32163122)
15. Allan, C. M., S. Taylor, and J. M. Taylor. 1997. Two hepatic enhancers, HCR.1 and HCR.2, coordinate the liver expression of the entire human apolipoprotein E/C-I/C-IV/C-II gene cluster. J. Biol. Chem. 272: 29113-29119. (Pubitemid 27498200)
16. Elshourbagy, N. A., W. S. Liao, R. W. Mahley, and J. M. Taylor. 1985. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl. Acad. Sci. USA. 82: 203-207. (Pubitemid 15168243)
17. Xu, Q., A. Bernardo, D. Walker, T. Kanegawa, R. W. Mahley, and Y. Huang. 2006. Profile and regulation of apolipoprotein E (apoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the apoE locus. J. Neurosci. 26: 4985-4994. (Pubitemid 44315280)
18. Goldstein, J. L., and M. S. Brown. 1976. The LDL pathway in human fibroblasts: a receptor-mediated mechanism for the regulation of cholesterol metabolism. Curr. Top. Cell. Regul. 11: 147-181.
19. Innerarity, T. L., and R. W. Mahley. 1978. Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. Biochemistry. 17: 1440-1447. (Pubitemid 8330378)
20. Innerarity, T. L., R. E. Pitas, and R. W. Mahley. 1979. Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. J. Biol. Chem. 254: 4186-4190.
21. Mahley, R. W., and Y. Huang. 2007. Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing. J. Clin. Invest. 117: 94-98. (Pubitemid 46048456)
22. Mahley, R. W., Y. Huang, and S. C. Rall, Jr. 1999. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes. J. Lipid Res. 40: 1933-1949. (Pubitemid 29523420)
23. Burt, T. D., B. K. Agan, V. C. Marconi, W. He, H. Kulkarni, J. E. Mold, M. Cavrois, Y. Huang, R. W. Mahley, M. J. Dolan, et al. 2008. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE e4/e4 genotype accelerates HIV disease progression. Proc. Natl. Acad. Sci. USA. 105: 8718-8723. (Pubitemid 351987746)
24. Morrow, J. A., K. S. Arnold, J. Dong, M. E. Balestra, T. L. Innerarity, and K. H. Weisgraber. 2000. Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor. J. Biol. Chem. 275: 2576-2580. (Pubitemid 30082023)
25. Wilson, C., M. R. Wardell, K. H. Weisgraber, R. W. Mahley, and D. A. Agard. 1991. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science. 252: 1817-1822. (Pubitemid 21917100)
26. Mahley, R. W., T. L. Innerarity, R. E. Pitas, K. H. Weisgraber, J. H. Brown, and E. Gross. 1977. Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins. J. Biol. Chem. 252: 7279-7287. (Pubitemid 8205564)
27. Weisgraber, K. H., T. L. Innerarity, and R. W. Mahley. 1978. Role of the lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. J. Biol. Chem. 253:9053-9062. (Pubitemid 9117020)
28. Lalazar, A., K. H. Weisgraber, S. C. Rall, Jr., H. Giladi, T. L. Innerarity, A. Z. Levanon, J. K. Boyles, B. Amit, M. Gorecki, R. W. Mahley, et al. 1988. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J. Biol. Chem. 263: 3542-3545. (Pubitemid 18078938)
29. Peters-Libeu, C. A., Y. Newhouse, D. M. Hatters, and K. H. Weisgraber. 2006. Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine. J. Biol. Chem. 281: 1073-1079.
30. Dong, L-M., S. Parkin, S. D. Trakhanov, B. Rupp, T. Simmons, K. S. Arnold, Y. M. Newhouse, T. L. Innerarity, and K. H. Weisgraber. 1996. Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia. Nat. Struct. Biol. 3: 718-722. (Pubitemid 26260063)
31. Huang, Y., S. C. Rall, Jr., and R. W. Mahley. 1997. Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2. Arterioscler. Thromb. Vasc. Biol. 17: 2817-2824. (Pubitemid 28016026)
32. Dong, L-M., and K. H. Weisgraber. 1996. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J. Biol. Chem. 271: 19053-19057. (Pubitemid 26271562)
33. Dong, L-M., C. Wilson, M. R. Wardell, T. Simmons, R. W. Mahley, K. H. Weisgraber, and D. A. Agard. 1994. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J. Biol. Chem. 269: 22358-22365.
34. Xu, Q., W. J. Brecht, K. H. Weisgraber, R. W. Mahley, and Y. Huang. 2004. Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer. J. Biol. Chem. 279: 25511-25516. (Pubitemid 38756810)
35. Hatters, D. M., M. S. Budamagunta, J. C. Voss, and K. H. Weisgraber. 2005. Modulation of apolipoprotein E structure by domain interaction. Differences in lipid-bound and lipid-free forms. J. Biol. Chem. 280: 34288-34295. (Pubitemid 41443154)
36. Ye, S., Y. Huang, K. Müllendorff, L. Dong, G. Giedt, E. C. Meng, F. E. Cohen, I. D. Kuntz, K. H. Weisgraber, and R. W. Mahley. 2005. Apolipoprotein (apo) E4 enhances amyloid β peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc. Natl. Acad. Sci. USA. 102: 18700-18705. (Pubitemid 43011289)
37. Raffaï, R. L., L-M. Dong, R. V. Farese, Jr., and K. H. Weisgraber. 2001. Introduction of human apolipoprotein E4 "domain interaction"into mouse apolipoprotein E. Proc. Natl. Acad. Sci. USA. 98: 11587-11591. (Pubitemid 32928772)
38. Huang, Y., X. Q. Liu, S. C. Rall, Jr., J. M. Taylor, A. von Eckardstein, G. Assmann, and R. W. Mahley. 1998. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J. Biol. Chem. 273: 26388-26393. (Pubitemid 28471643)
39. Kuipers, F., M. C. Jong, Y. Lin, M. van Eck, R. Havinga, V. Bloks, H. J. Verkade, M. H. Hofker, H. Moshage, T. J. C. van Berkel, et al. 1997. Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E-deficient mouse hepatocytes. J. Clin. Invest. 100:2915-2922. (Pubitemid 28007563)
40. Corder, E. H., A. M. Saunders, W. J. Strittmatter, D. E. Schmechel, P. C. Gaskell, G. W. Small, A. D. Roses, J. L. Haines, and M. A. Pericak- Vance. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261: 921-923. (Pubitemid 23275809)
41. Ji, Z-S., R. D. Miranda, Y. M. Newhouse, K. H. Weisgraber, Y. Huang, and R. W. Mahley. 2002. Apolipoprotein E4 potentiates amyloid β peptide-induced lysosomal leakage and apoptosis in neuronal cells. J. Biol. Chem. 277: 21821-21828. (Pubitemid 34952334)
42. Ji, Z-S., K. Müllendorff, I. H. Cheng, R. D. Miranda, Y. Huang, and R. W. Mahley. 2006. Reactivity of apolipoprotein E4 and amyloid b peptide: lysosomal stability and neurodegeneration. J. Biol. Chem. 281: 2683-2692. (Pubitemid 43845731)
43. Xu, Q., D. Walker, A. Bernardo, J. Brodbeck, M. E. Balestra, and Y. Huang. 2008. Intron-3 retention/splicing controls neuronal expression of apolipoprotein E in the CNS. J. Neurosci. 28: 1452-1459. (Pubitemid 351231537)
44. Harris, F. M., W. J. Brecht, Q. Xu, I. Tesseur, L. Kekonius, T. Wyss- Coray, J. D. Fish, E. Masliah, P. C. Hopkins, K. Scearce-Levie, et al. 2003. Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc. Natl. Acad. Sci. USA. 100: 10966-10971. (Pubitemid 37140136)
45. Brecht, W. J., F. M. Harris, S. Chang, I. Tesseur, G-Q. Yu, Q. Xu, J. D. Fish, T. Wyss-Coray, M. Buttini, L. Mucke, et al. 2004. Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J. Neurosci. 24:2527-2534. (Pubitemid 38327965)
46. Chang, S., T. R. Ma, R. D. Miranda, M. E. Balestra, R. W. Mahley, and Y. Huang. 2005. Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc. Natl. Acad. Sci. USA. 102:18694-18699. (Pubitemid 43011288)
47. Brodbeck, J., M. E. Balestra, A. M. Saunders, A. D. Roses, R. W. Mahley, and Y. Huang. 2008. Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons. Proc. Natl. Acad. Sci. USA. 105: 1343-1346. (Pubitemid 351397055)
48. Sinnis, P., T. E. Willnow, M. R. S. Briones, J. Herz, and V. Nussenzweig. 1996. Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes. J. Exp. Med. 184: 945-954.
49. Roselaar, S. E., and A. Daugherty. 1998. Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J. Lipid Res. 39: 1740-1743. (Pubitemid 28411160)
50. de Bont, N., M. G. Netea, P. N. M. Demacker, I. Verschueren, B. J. Kullberg, K. W. van Dijk, J. W. M. van der Meer, and A. F. H. Stalenhoef. 1999. Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J. Lipid Res. 40: 680-685. (Pubitemid 29173771)
51. Itzhaki, R. F., W-R. Lin, D. Shang, G. K. Wilcock, B. Faragher, and G. A. Jamieson. 1997. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet. 349: 241-244. (Pubitemid 27050990)
52. Martin, I., M-C. Dubois, T. Saermark, and J-M. Ruysschaert. 1992. Apolipoprotein A-1 interacts with the N-terminal fusogenic domains of SIV (simian immunodeficiency virus) GP32 and HIV (human immunodeficiency virus) GP41: implications in viral entry. Biochem. Biophys. Res. Commun. 186: 95-101.
53. Finch, C. E., and R. M. Sapolsky. 1999. The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol. Aging. 20: 407-428.
54. Mahley, R. W., and S. C. Rall, Jr. 1999. Is e4 the ancestral human apoE allele? Neurobiol. Aging. 20: 429-430.
55. Gerdes, L. U. 2003. The common polymorphism of apolipoprotein E: geographical aspects and new pathophysiological relations. Clin. Chem. Lab. Med. 41: 628-631.
56. Zhong, N., and K. H. Weisgraber. Understanding the association of apolipoprotein E4 with Alzheimer's disease: clues from its structure. J. Biol. Chem. Epub ahead of print. October 22, 2008. 10.1074/jbc.R800009200.
57. Mahley, R. W., and Y. Huang. 1999. Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. Curr. Opin. Lipidol. 10:207-217. (Pubitemid 29405911)